Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial
Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4. This appears to be a minor template or platform update with no changes to the study details or user interactions.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision updates to version v3.6.3, signaling a small update to the study record. There are no visible changes to the study details or user-facing information.SummaryDifference0.1%

- Check35 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer published version without describing substantive content changes.SummaryDifference0.1%

- Check49 days agoChange DetectedNew user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the page revision shows Revision: v3.6.0. Additionally, the recruitment status was updated to 'No longer looking for participants', signaling that enrollment for this study has closed.SummaryDifference0.4%

- Check57 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a backend content-management update that does not change the displayed study information.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision tag updated to v3.5.4, indicating a minor platform update on the page. The update does not alter the study details or other content displayed.SummaryDifference0.1%

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.